De novo grown bone on exposed implant surfaces using photodynamic therapy and recombinant human bone morphogenetic protein-2: Case report

Implant Dentistry

Volumn 15, Issue 4, 2006, Pages 361-365

  Schuckert, Karl Heinz ^a   Jopp, Stefan ^a   Muller, Ulrich ^a  

^a Centre for Tissue Engineering   (Germany)

Author keywords

Biofilms; Bone morphogenetic protein; Grown bone; Photodynamic therapy; Recombinant human bone morphogenetic protein 2

Indexed keywords

BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN; DRUG CARRIER; GELATIN SPONGE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE DEVELOPMENT; CASE REPORT; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; LASER; OSTEOLYSIS; PERIODONTITIS; PHOTOCHEMOTHERAPY; TOOTH IMPLANTATION;

ADULT; ALVEOLAR BONE LOSS; BONE MORPHOGENETIC PROTEINS; DENTAL IMPLANTS; DRUG CARRIERS; FEMALE; FOLLOW-UP STUDIES; GELATIN SPONGE, ABSORBABLE; HUMANS; LASERS; OSTEOGENESIS; PERIODONTITIS; PHOTOCHEMOTHERAPY; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845799618     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000247856.09740.3f     Document Type: Article

References (20)

1. Quirynen M, De Soete M, van Steenberghe D. Infectious risks for oral implants: A review of the literature. Clin Oral Implants Res. 2002;13:1-19.
2. Deppe H, Greim H, Brill T, et al. Titanium deposition after peri-implant care with the carbon dioxide laser. Int J Oral Maxillofac Implants. 2002;17:707-714.
3. Kreisler M, Kohnen W, Marinello C, et al. Bactericidal effect of the Er:YAG laser on dental implant surfaces: An in vitro study. J Periodontol. 2002;73:1292-1298.
4. Dörtbudak O, Haas R, Bernhard T, et al. Lethal photosensitization for decontamination of implant surfaces in the treatment of periimplantitis. Clin Oral Implants Res. 2001;12:104-108.
5. Wilson M, Dobson J, Sarkar S. Sensitization of periodontopathogenic bacteria to killing by light from a low-power laser. Oral Microbiol Immunol. 1993;8:182-187.
6. Wilson M. Bactericidal effect of laser light and its potential use in the treatment of plaque-related diseases. Int Dent J. 1994;44:181-189.
7. Pearson GJ, Schuckert KH. The role of lasers in dentistry: Present and future. Dent Update. 2003;30:70-76.
8. Bonneau R, Pottier R, Bagno O, et al. pH dependence of singlet oxygen production in aqueous solutions using thiazine dyes as photosensitizers. Photochem Photobiol. 1975;21:159-163.
9. Dobson J, Wilson M. Sensitization of oral bacteria in biofilms to killing by light from a low-power laser. Arch Oral Biol. 1992;37:883-887.
10. Usacheva MN, Teichert MC, Biel MA. Comparison of the methylene blue and toluidine blue photobactericidal efficacy against gram-positive and gram-negative microorganisms. Lasers Surg Med. 2001;29:165-173.
11. Wainwright M, Phoenix DA, Marland J, et al. A study of photobactericidal activity in the phenothiazinium series. FEMS Immunol Med Microbiol. 1997;19:75-80.
12. Schindl A. Does low intensity laser irradiation really cause cell damage? Lasers Surg Med. 2001;29:105-106.
13. Soukos NS, Wilson M, Burns T, et al. Photodynamic effects of toluidine blue on human oral keratinocytes and fibroblasts and Streptococcus sanguis evaluated in vitro. Lasers Surg Med. 1996;18:253-259.
14. Wilson M, Dobson J, Harvey W. Sensitization of oral bacteria to killing by low-power laser radiation. Curr Microbiol. 1992;25:77-81.
15. Urist MR. Bone: Formation by autoinduction. Science. 1965;150:893-899.
16. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent. 1997;17:124-139.
17. Cochran DL, Jones AA, Lilly LC, et al. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol. 2000;71:1241-1257.
18. Fiorellini J, Howell T, Cochran D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol. 2005;76:605-613.
19. Boyne PJ, Lilly LC, Marx RE, et al. De novo bone induction by recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg. 2005;63:1693-1707.
20. Schuckert KH, Jopp S, Muller U. Bone tissue engineering with BMPs-First experiences and results in oral surgery by using rhBMP-2 in humans. Int J Oral Maxillofac Surg. 2005;34(suppl 1):68.